Company: STAA
Filing Date: 2025-12-09
Form Type: DFAN14A
Source: 0001213900-25-119731
Chunk: 4

Company: STAAR SURGICAL CO
Filing Date: 2025-12-09
Form: DFAN14A
Chunk 4
---
 CEO’s
personal pocketbook. The Board dismissed these concerns for months. But now, facing one of the worst say-on-golden-parachute-pay votes
ever, the Board finally has admitted its mistake and relented on this point too.

In our view, this proposed transaction
has been plagued by missteps from the very beginning. We believe the Board ran an irredeemably flawed process, at the wrong time, that
resulted in a proposed sale of the Company for a manifestly inadequate price. Although the Board eventually sought to address these defects
by belatedly negotiating a meager price bump, how can shareholders have any confidence that this latest offer represents the best one
available given the manifold process, timing, price and incentive issues?

We do not seek – and have never
sought – control of STAAR, but we are large owners and are enthusiastic about continuing to own our share of the business as it
turns the corner after some self-inflicted wounds in 2024. We believe STAAR has a bright future as an independent company. In fact, if
the Company achieves management’s own projections, STAAR will be one of the most profitable medical technology companies in the
world. Based on this fact, we believe the Company is worth substantially more than $30.75 per share.

We have no confidence in this deeply
conflicted Board or the process it has overseen, nor do we believe the Board has maximized value for shareholders.

We therefore intend to vote “AGAINST”
the revised transaction at the upcoming meeting, and we urge other shareholders to do the same.”

If you have any questions or require any assistance
with voting your shares, please contact our proxy solicitor, Saratoga Proxy Consulting LLC, by calling (212) 257-1311 or toll free at
(888) 368-0379, or by email at info@saratogaproxy.com. If you have already voted for the merger, you may change your vote by voting a
later-dated proxy “AGAINST” the deal. Only your latest dated vote counts.

About Broadwood

Broadwood Partners, L.P. is managed by Broadwood
Capital, Inc. Broadwood Capital is a private investment firm based in New York City. Neal Bradsher is the President of Broadwood Capital.

Certain Information Concerning the Participants

Broadwood Partners, L.P., Broadwood Capital, Inc.,
Neal C. Bradsher, Richard T. LeBuhn, Natalie R